Arcutis Posts 6-Cent Q3 EPS as Stock Sits Near 52-Week High
ARQT sits 77% above its 52-week low of $19.295.
Summary
Arcutis reported third-quarter earnings per share of 6 cents, per Dow Jones Newswires, with revenue of $143.9 million and product revenue up 45% on ZORYVE demand. That follows a strong second quarter, when the company posted $15.0 million of net income on $129.9 million of product revenue, up 59% year-over-year on ZORYVE sales. The company raised its FY26 net product sales guidance to $535 M-$545 M. The shares are trading near their 52-week high, so the print lands with expectations already elevated.
At the time of this announcement, ARQT was trading at $34.23 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $19.30 to $34.80. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.